Literature DB >> 33374432

Correlation of Computed Tomography Parameters with Histology, Stage and Prognosis in Surgically Treated Thymomas.

Angelo Carretta1,2, Stefano Viscardi1, Piergiorgio Muriana1, Paola Ciriaco1, Alessandro Bandiera1, Roberto Varagona3, Michele Colombo3, Giampiero Negri1,2.   

Abstract

Background and objectives: The histological classification and staging of thymic tumors remains a matter of debate. The correlation of computed tomography (CT) parameters with tumor histology and stage also still has to be completely assessed. The aim of this study was therefore to analyze the correlation of radiological parameters with histological and staging classifications of thymomas evaluating their prognostic role.
Methods: Data of 50 patients with thymoma submitted to a complete surgical treatment between 2005 and 2015 were retrospectively analyzed. Tumors were classified according to the WHO and Suster and Moran (S&M) histological classifications and to the Masaoka-Koga and tumor, node and metastases (TNM) staging systems. The correlation of CT features with histology and stage and the prognostic role of histopathological and radiological features were assessed.
Results: Five-year overall (OS) and disease-free survival (DFS) were 90.3% and 81.1%, respectively. A significant correlation of DFS with the Masaoka-Koga (p = 0.001) and TNM staging systems (p = 0.002) and with the S&M (p = 0.02) and WHO histological classifications (p = 0.04) was observed. CT scan features correlated with tumor stage, histology and prognosis. Moderately differentiated tumors (WHO B3) had a significantly higher incidence of irregular shape and contours (p = 0.002 and p = 0.001, respectively) and pericardial contact (p = 0.036). A larger tumor volume (p = 0.03) and a greater length of pleural contact (p = 0.04) adversely influenced DFS. The presence of pleural (p < 0.001) or lung invasion (p = 0.02) and of pleural effusion (p = 0.004) was associated with a significantly worse OS. Conclusions: Pre-operative CT scan parameters correlate with stage and histology, and have a prognostic role in surgically treated thymomas.

Entities:  

Keywords:  CT; histology; prognosis; staging; surgery; thymoma

Mesh:

Year:  2020        PMID: 33374432      PMCID: PMC7824084          DOI: 10.3390/medicina57010010

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  25 in total

Review 1.  Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms.

Authors:  S Suster; C A Moran
Journal:  Am J Clin Pathol       Date:  1999-06       Impact factor: 2.493

2.  Lymphogenous and hematogenous metastasis of thymic epithelial tumors.

Authors:  Kazuya Kondo; Yasumasa Monden
Journal:  Ann Thorac Surg       Date:  2003-12       Impact factor: 4.330

3.  Is thymectomy necessary in nonmyasthenic patients with early thymoma?

Authors:  Yen-Chiang Tseng; Chih-Cheng Hsieh; Hsin-Yi Huang; Chien-Sheng Huang; Wen-Hu Hsu; Biing-Shiun Huang; Min-Hsiung Huang; Han-Shui Hsu
Journal:  J Thorac Oncol       Date:  2013-07       Impact factor: 15.609

4.  A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma.

Authors:  K Koga; Y Matsuno; M Noguchi; K Mukai; H Asamura; T Goya; Y Shimosato
Journal:  Pathol Int       Date:  1994-05       Impact factor: 2.534

5.  ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting.

Authors:  Alexander Marx; Philipp Ströbel; Sunil S Badve; Lara Chalabreysse; John K C Chan; Gang Chen; Laurence de Leval; Frank Detterbeck; Nicolas Girard; Jim Huang; Michael O Kurrer; Libero Lauriola; Mirella Marino; Yoshihiro Matsuno; Thierry Jo Molina; Kiyoshi Mukai; Andrew G Nicholson; Daisuke Nonaka; Ralf Rieker; Juan Rosai; Enrico Ruffini; William D Travis
Journal:  J Thorac Oncol       Date:  2014-05       Impact factor: 15.609

6.  Lymph node metastasis in thymic malignancies: A Chinese multicenter prospective observational study.

Authors:  Wentao Fang; Yun Wang; Liewen Pang; Zhitao Gu; Yucheng Wei; Yongyu Liu; Peng Zhang; Chun Chen; Xinming Zhou; Yangchun Liu; Keneng Chen; Jianyong Ding; Yongtao Han; Yin Li; Zhentao Yu; Yuan Liu; Jianhua Fu
Journal:  J Thorac Cardiovasc Surg       Date:  2018-04-18       Impact factor: 5.209

7.  The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: The Impact of the Eighth Edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors.

Authors:  Enrico Ruffini; Wentao Fang; Francesco Guerrera; James Huang; Meinoshin Okumura; Dong Kwan Kim; Nicolas Girard; Andrea Billè; Souheil Boubia; Ayten Kayi Cangir; Frank Detterbeck; Conrad Falkson; Pier Luigi Filosso; Giuseppe Giaccone; Kazuya Kondo; Maurizio Infante; Marco Lucchi; Mirella Marino; Edith M Marom; Andrew G Nicholson; Andreas Rimner; Ramon Rami-Porta; Hisao Asamura
Journal:  J Thorac Oncol       Date:  2019-11-27       Impact factor: 15.609

Review 8.  The clinical features, diagnosis and management of recurrent thymoma.

Authors:  Taobo Luo; Hongguang Zhao; Xinming Zhou
Journal:  J Cardiothorac Surg       Date:  2016-08-31       Impact factor: 1.637

9.  Relationship Between Computed Tomography Imaging Features and Clinical Characteristics, Masaoka-Koga Stages, and World Health Organization Histological Classifications of Thymoma.

Authors:  Xiaowei Han; Wenwen Gao; Yue Chen; Lei Du; Jianghui Duan; Hongwei Yu; Runcai Guo; Lu Zhang; Guolin Ma
Journal:  Front Oncol       Date:  2019-10-11       Impact factor: 6.244

10.  Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME).

Authors:  Martina Imbimbo; Margaret Ottaviano; Milena Vitali; Alessandra Fabbri; Giovanni Leuzzi; Michele Fiore; Davide Franceschini; Giulia Pasello; Matteo Perrino; Marco Schiavon; Giancarlo Pruneri; Angelo Paolo Dei Tos; Claudia Sangalli; Marina Chiara Garassino; Rossana Berardi; Alessandra Alessi; Giuseppina Calareso; Iacopo Petrini; Marta Scorsetti; Vieri Scotti; Lorenzo Rosso; Federico Rea; Ugo Pastorino; Paolo Giovanni Casali; Sara Ramella; Umberto Ricardi; Laura Abate-Daga; Valter Torri; Annalisa Trama; Giovannella Palmieri; Mirella Marino; Paolo Andrea Zucali
Journal:  Cancer Treat Rev       Date:  2018-10-05       Impact factor: 12.111

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.